View in EDS

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.

Saved in:
Bibliographic Details
Title: Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Authors: Ferdowsi N; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Huq M; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Stevens W; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Hudson M; Medicine, University of McGill, Montreal, Quebec, Canada., Wang M; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada., Tay T; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Burchell JL; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Mancuso S; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Rabusa C; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Sundararajan V; Public Health, LaTrobe University, Melbourne, Victoria, Australia., Prior D; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Proudman SM; Rheumatology, Royal Adelaide Hospital, Adelaide, Victoria, Australia., Baron M; Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada., Nikpour M; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia m.nikpour@unimelb.edu.au.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.
Corporate Authors: Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group, Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Jun; Vol. 78 (6), pp. 807-816. Date of Electronic Publication: 2019 Mar 30.
Publication Type: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30928903
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferdowsi+N%22">Ferdowsi N</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Huq+M%22">Huq M</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Stevens+W%22">Stevens W</searchLink>; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Hudson+M%22">Hudson M</searchLink>; Medicine, University of McGill, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Tay+T%22">Tay T</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Burchell+JL%22">Burchell JL</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Mancuso+S%22">Mancuso S</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Rabusa+C%22">Rabusa C</searchLink>; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Sundararajan+V%22">Sundararajan V</searchLink>; Public Health, LaTrobe University, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Prior+D%22">Prior D</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Proudman+SM%22">Proudman SM</searchLink>; Rheumatology, Royal Adelaide Hospital, Adelaide, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Baron+M%22">Baron M</searchLink>; Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Nikpour+M%22">Nikpour M</searchLink>; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia m.nikpour@unimelb.edu.au.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Scleroderma+Clinical+Trials+Consortium+Damage+Index+Working+Group%2C+The+Australian+Scleroderma+Interest+Group%2C+Canadian+Scleroderma+Research+Group%22">Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group</searchLink><br /><searchLink fieldCode="CA" term="%22Scleroderma+Clinical+Trials+Consortium+Damage+Index+Working+Group%2C+TheAustralian+Scleroderma+Interest+Group%2C+Canadian+Scleroderma+Research+Group%22">Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372355%22">Annals of the rheumatic diseases</searchLink> [Ann Rheum Dis] 2019 Jun; Vol. 78 (6), pp. 807-816. <i>Date of Electronic Publication: </i>2019 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-2060 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034967%22">00034967 </searchLink><i>NLM ISO Abbreviation: </i>Ann Rheum Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30928903
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/annrheumdis-2018-214764
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 807
    Titles:
      – TitleFull: Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferdowsi N
      – PersonEntity:
          Name:
            NameFull: Huq M
      – PersonEntity:
          Name:
            NameFull: Stevens W
      – PersonEntity:
          Name:
            NameFull: Hudson M
      – PersonEntity:
          Name:
            NameFull: Wang M
      – PersonEntity:
          Name:
            NameFull: Tay T
      – PersonEntity:
          Name:
            NameFull: Burchell JL
      – PersonEntity:
          Name:
            NameFull: Mancuso S
      – PersonEntity:
          Name:
            NameFull: Rabusa C
      – PersonEntity:
          Name:
            NameFull: Sundararajan V
      – PersonEntity:
          Name:
            NameFull: Prior D
      – PersonEntity:
          Name:
            NameFull: Proudman SM
      – PersonEntity:
          Name:
            NameFull: Baron M
      – PersonEntity:
          Name:
            NameFull: Nikpour M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2019 Jun
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1468-2060
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Annals of the rheumatic diseases
              Type: main
ResultId 1